(RECS) Columbia Trust I - Columbia - Overview
Etf: Large-Cap, Mid-Cap, Growth, Value, US
Dividends
| Dividend Yield | 1.12% |
| Yield on Cost 5y | 2.23% |
| Yield CAGR 5y | -46.53% |
| Payout Consistency | 79.7% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 13.2% |
| Relative Tail Risk | 3.36% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.71 |
| Alpha | 2.45 |
| Character TTM | |
|---|---|
| Beta | 0.941 |
| Beta Downside | 0.948 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.60% |
| CAGR/Max DD | 1.14 |
Description: RECS Columbia Trust I - Columbia January 11, 2026
The Columbia Research Enhanced Core ETF (NYSE ARCA: RECS) tracks a rules-based subset of the Russell 1000® Index, allocating at least 80 % of its assets to the index’s constituents. The index targets U.S. large- and mid-cap growth and value stocks, typically holding between 325 and 400 securities, though the exact count can vary because there is no fixed cap on holdings.
Key data points (as of Q3 2024) include an expense ratio of roughly 0.30 % and assets under management of about $200 million, with an annual turnover rate near 30 %. Sector exposure is weighted toward technology (≈30 %), consumer discretionary (≈20 %), and health care (≈15 %). Performance is sensitive to macro drivers such as U.S. GDP growth and the Federal Reserve’s interest-rate policy, which tend to affect growth versus value dynamics across these sectors.
If you want a more granular view of RECS’s risk-adjusted returns and factor breakdowns, a quick look at ValueRay’s analytics can help you assess whether it fits your portfolio objectives.
What is the price of RECS shares?
Over the past week, the price has changed by +0.46%, over one month by -0.07%, over three months by +3.97% and over the past year by +16.79%.
Is RECS a buy, sell or hold?
What are the forecasts/targets for the RECS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 49.1 | 18.6% |
RECS Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 5.07b USD (5.07b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 5.07b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 5.07b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.38% (E(5.07b)/V(5.07b) * Re(9.38%) + (debt-free company))
Discount Rate = 9.38% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)